Effect of Ischemic Preconditioning on Atrial Fibrillation After Electrocardioversion
- Conditions
- Atrial Fibrillation
- Interventions
- Procedure: Remote ischemic preconditioningProcedure: Sham preconditioning
- Registration Number
- NCT05342220
- Lead Sponsor
- St. Josefs-Hospital Wiesbaden GmbH
- Brief Summary
Remote ischemic preconditioning is one way to influence the success of therapy in cardiovascular patients. By means of remote ischemic preconditioning the incidence of atrial fibrillation after cardiac surgery was reduced by 54%. The investigators aim to investigate the effect of ischemic preconditioning in an easy-to-perform protocol with regard to the recurrence of atrial fibrillation after electrical cardioversion.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 240
- Patients with paroxysmal or persistent atrial fibrillation who give written informed consent to participate in the study
- Age > 18 years
- Consent capacity
- Age under 18 years
- Pregnancy
- Lack of consent capacity
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Remote Ischemic Preconditioning Remote ischemic preconditioning Remote ischemic preconditioining Control Sham preconditioning Sham preconditioning
- Primary Outcome Measures
Name Time Method Number of subjects with recurrence of atrial fibrillation 30 days after electrical cardioversion 30 days
- Secondary Outcome Measures
Name Time Method Minimum energy required for successful electrocardioversion (in Joule) 30 days Cumulative energy applied for successfull electrocardioversion (in Joule) 30 days Number of patients with short-term cardioversion success 30 seconds Sinus rhythm lasting \> 30 seconds after electrocardioversion
Cumulative number of shocks delivered for successfull electrocardioversion 30 days Number of patients experiencing death from any cause, stroke /transient ischemic attack, relevant post-ECV arrhythmia and procedure-associated complications 30 days Safety endpoint
Trial Locations
- Locations (1)
St. Josefs-Hospital Wiesbaden
🇩🇪Wiesbaden, Hessen, Germany